Related Experiment Video
Updated: Jan 29, 2026

Orthopedic Robot-Assisted Femoral Neck System in the Treatment of Femoral Neck Fracture
Published on: March 3, 2023
Hybrid procedures and femoral endarterectomy in diabetic patients
R N Berchiolli1, M Marconi, D M Mocellin
1Vascular Surgery Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy. michemarconi@gmail.com.
Insights
Hybrid procedures combining common femoral endarterectomy (CFE) and endovascular revascularization are safe and effective for critical limb ischemia (CLI). These hybrid approaches show comparable outcomes in diabetic and non-diabetic patients.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Critical Limb Ischemia Management
Background:
- Critical limb ischemia (CLI) poses a significant challenge, often requiring complex revascularization strategies.
- Hybrid procedures integrating open and endovascular techniques are increasingly utilized for CLI.
- Evaluating the safety and effectiveness of these hybrid approaches in diverse patient populations is crucial.
Purpose of the Study:
- To assess the safety and effectiveness of common femoral endarterectomy (CFE) combined with endovascular revascularization (EV) in patients with CLI.
- To compare outcomes in diabetic (type 1 and type 2) versus non-diabetic patients undergoing these hybrid procedures.
- To analyze the impact of proximal and/or distal EV procedures in conjunction with CFE.
Main Methods:
- A retrospective analysis of patients who underwent one-staged hybrid procedures for CLI between January 2008 and December 2011.
- Patients were categorized into three groups based on the location of EV relative to CFE: proximal, distal, or both.
- Follow-up evaluations were conducted at 6 and 36 months, with a mean follow-up of 42 months.
Main Results:
- Out of 635 patients with CLI, 43 met the inclusion criteria for hybrid procedures; 53.5% had diabetes mellitus (DM).
- Common femoral endarterectomy (CFE) was universally successful, with a 90.7% success rate for associated endovascular procedures.
- Survival rates at 36 months were 71.9%, with a cumulative limb salvage of 92.1%. No significant differences were observed between diabetic and non-diabetic patients or among the EV groups.
Conclusions:
- Hybrid procedures involving CFE and EV revascularization are safe and effective for managing CLI.
- These hybrid approaches demonstrate comparable outcomes in both diabetic and non-diabetic patients.
- Consideration of hybrid procedures is warranted when indications for CLI treatment are present.
Objective:
The aim of the study is to evaluate the safety and effectiveness of common femoral endarterectomy (CFE) in critical limb ischemia (CLI) associated with proximal and distal endovascular (EV) revascularization in diabetic (type 1 and type 2) and non-diabetic patients.
Patients And Methods:
We analyzed patients from January 2008 to December 2011 who underwent one-staged hybrid procedures. Patients were divided into three groups: group 1 = EV reconstruction proximal to the CFE, group 2 = EV procedures distal to the CFE, group 3 = both proximal and distal EV procedures. Patients were evaluated at 6 and 36 months after the procedures, and the mean follow-up was 42 ± 20.3 months.
Results:
A total of 43 (79% men; aged 74.4 ± 8.6 years) out of 635 (5.5%) patients operated for CLI fulfilled the inclusion criteria; 23 (53.5%) had type 1 or type 2 diabetes mellitus (DM). DM patients were younger than controls (p = 0.048). The patient distribution was 14 in Group 1 (32.5%), 24 in Group 2 (55.8%) and 5 in Group 3 (11.7%). CFE was successful in all cases, while associated EV procedures were successful in 90.7% of patients. Peri-operative morbidity and mortality were 11.6% and 2.3%, respectively. Survival rates at 6 and 36 months were 93% and 71.9%, respectively. Three patients (6.98%) underwent a major amputation. The cumulative limb salvage was 95.2% at 6 months and 92.1% at 36 months. No recurrent CFE stenosis was observed. No differences in survival, amputation or patency rates emerged between DM and non-DM patients or among the three EV revascularization groups.
Conclusions:
Hybrid procedures are safe and effective both in CLI patients with or without DM, and they should be taken into consideration whenever indications are present.
Related Concept Videos
Hybrid Zones
Hybridization of Atomic Orbitals I
Hybridization of Atomic Orbitals II
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

